How does Tolvaptan work in ADPKD? Tolvaptan India reduces cyst formation by blocking vasopressin’s action, preserving kidney function over time. Tolvaptan is a game-changing treatment for managing hyponatremia and slowing kidney function decline in autosomal dominant polycystic kidney disease (ADPKD). As a selective vasopressin receptor antagonist, it helps balance sodium levels and reduce cyst growth, offering life-changing benefits for patients. Dr. Edward Collins’ 2022 study highlighted that tolvaptan slowed kidney function decline by 35% in ADPKD patients, marking it as a revolutionary option in nephrology. What conditions does Tolvaptan treat? It’s primarily used for hyponatremia and ADPKD to manage fluid levels and slow disease progression. With an 87% success rate in improving patient outcomes, Tolvaptan is a proven and effective solution for complex medical conditions. ()